Clinical Trials for Lymphoma, Mantle-Cell

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

NCT ID: NCT06045910

This clinical trial is studying a new treatment called ALETA-001 for patients with certain types of B-cell cancers, including different forms of lymphoma. Specifically, it is looking at how safe an...

A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or Relapsed/Refractory High-risk Mantle-cell Lymphoma

NCT ID: NCT06558604

This clinical trial is looking at how effective a combination of three medications—Glofitamab, Venetoclax, and Zanubrutinib—are in treating people with high-risk mantle cell lymphoma (MCL), a type ...

A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer

NCT ID: NCT05659732

This clinical trial is studying a new treatment called PEP07, which is a pill taken once a day, for patients with advanced cancers like Acute Myeloid Leukemia (AML) and Mantle Cell Lymphoma (MCL). ...

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT ID: NCT06427213

This clinical trial is testing a new treatment called Zanubrutinib for patients who have recently been diagnosed with mantle cell lymphoma, a type of non-Hodgkin lymphoma. It aims to see how effect...

A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT ID: NCT06136351

This clinical trial is studying a new treatment approach for patients with newly diagnosed mantle cell lymphoma, a type of blood cancer. The treatment combines three medications: Zanubrutinib, bend...

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

NCT ID: NCT04911478

Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL

NCT ID: NCT04913103

This clinical trial is studying a new treatment approach for patients with mantle cell lymphoma (MCL) who have not responded to previous therapies, specifically those who have been treated with Bru...